Cusbada fosfateedka

Qanacsan

• Waxtar u leh ...
• Waxtar u leh ...
• Suurtagal inay wax ku ool u tahay ...
• Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...
• Taxaddarrada gaarka ah & digniinta:

Cusbada fosfate waxaa loola jeedaa iskudhafyo badan oo kala duwan oo ah kiimikada fosfat ee cusbada iyo macdanta. Cunnooyinka ay ku badan tahay fosfateerka waxaa ka mid ah waxyaabaha caanaha laga sameeyo, badarka miraha laga sameeyo, iniinyaha, iyo hilibka qaarkood. Fosfooyinka laga helo waxyaabaha caanaha laga sameeyo iyo hilibka ayaa umuuqda kuwa si fudud jidhku u nuugo marka loo eego fosfooraska laga helo badarka. Cabitaanka Cola-ka waxaa ku jira fosfooras badan - aad iyo aad, runtii, in ay ku sababi karaan fosfateet aad u badan dhiiga.

Dadku waxay dawo u isticmaalaan cusbada fosfateerka. Ka taxaddar inaadan ku khaldin cusbada fosfateerka maadooyinka sida organophosphates, oo aad sun u ah.

Cusbada fosfateerka ayaa badanaa loo isticmaalaa nadiifinta mindhicirka, heerarka dhiigga ee hooseeya ee fosfateerka, calool istaagga, heerarka dhiigga ee kaalshiyamka, iyo laabjeexa.

Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran waxay qiimeysaa waxtarka ku saleysan caddeynta sayniska iyadoo loo eegayo cabirka soo socda: Wax ku ool ah, Suurta gal ah inuu wax ku ool yahay, suurtagal tahay wax ku ool ah, macquul ahaan waxtar la'aan, suurtagal ahaan waxtar la'aan, waxtar la'aan, iyo caddayn ku filan oo lagu qiimeeyo.

Qiimeynta waxtarka ee XADGUDUBKA FARSAMADA waa sida soo socota:

Waxtar u leh ...

• U diyaarinta mindhicirka hawl caafimaad. Qaadashada alaabta sodium fosfateerka afka kahor qalliinka baarista walamadka waxay waxtar u leedahay nadiifinta mindhicirka. Qaar ka mid ah alaabada sodium fosfate (OsmoPrep, Salix Pharmaceuticals; Visicol, Salix Pharmaceuticals) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee Mareykanka (FDA) tilmaamahan. Si kastaba ha noqotee, qaadashada sodium fosfate waxay kordhin kartaa halista in kilyaha waxyeelleeyaan dadka qaar. Sababtaas awgeed, alaabada sodium fosfateerka looma adeegsado Mareykanka si loogu diyaariyo caloosha.
• Heerarka fosfateerka ee dhiigga ku jira. Qaadashada sodium ama potassium fosfateerka afku waxay waxtar u leedahay ka hortagga ama daaweynta heerarka fosfateerka dhiigga ku hooseeya. Cusbada faleebada faleebada ayaa sidoo kale daaweyn karta heerarka fosfateerka dhiigga ku yar marka lagu isticmaalo kormeerka takhtarka.

Waxtar u leh ...

• Calool fadhiga. Sodium fosfate waa qayb FDA-ka loo oggol yahay oo laga iibsado (OTC) oo loogu talagalay daaweynta calool istaagga. Wax soo saarkan waxaa laga qaadaa afka ama waxaa loo isticmaalaa sida enemas.
• Dheef-shiidka. Aluminium fosfateerka iyo kaalshiyamka fosfateerka ayaa ah maaddooyinka loo ogol yahay in loo isticmaalo daawada loo yaqaan 'antacids' ee loo yaqaan "FDA".
• Heerarka kaalshiyamka ee dhiigga ku jira. Qaadashada cusbada fosfateerka (marka laga reebo kalsiyum fosfate) afka ayaa laga yaabaa inay waxtar u leedahay daaweynta heerarka sare ee kaalshiyamka dhiigga ku jira. Laakiin cusbada fosfateerka ee xididka laguma isticmaalo.

Suurtagal inay wax ku ool u tahay ...

• Dhagaxyada kilyaha (nephrolithiasis). Qaadashada potassium fosfateerka afku waxay kaa caawin kartaa ka hortagga dhagxaanta kalyaha ee kalsiyum inay ku samaysmaan bukaanada leh heerarka kaadi ee kalsiyum.

Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...

• Waxqabadka Ciyaaraha. Qaar ka mid ah cilmibaaristii hore waxay muujinayaan in qaadashada sodium fosfateerka afka 6 maalmood ka hor baaskiil xoog badan ama orodku ay hagaajin karto waxqabadka cayaaraha. Laakiin cilmi baaris kale oo hore ayaa muujineysa inaysan jirin wax faa'iido ah. Daraasado badan ayaa looga baahan yahay kooxo badan oo dad ah si ay u arkaan waa sodium fosfate runti faa'iido badan ayey leedahay. Qaadashada cusbada kale ee fosfateerka sida kaalshiyamka fosfateerka ama kaalshiyamka fosfate ma hagaajinayo orodka ama waxqabadka baaskiil wadista.
• Dhibaatada sonkorowga (ketoacidosis sonkorow). Daraasad hore waxay muujineysaa in siinta fosfate fosfooraska faleebada (ee IV) aysan hagaajinaynin cudurka sonkorowga kaas oo jidhku soo saaro asiidh badan oo dhiig ah oo loo yaqaan ketones. Dadka xaaladan qaba waa in la siiyaa fosfooras haddii ay leeyihiin heerar fosfateed oo hooseeya.
• Cudurka Osteoporosis. Cilmi baaris ayaa muujisay in qaadashada kaalshiyamka afka laga qaato ay ka caawiso hagaajinta cufnaanta lafaha miskaha iyo lafdhabarta hoose ee haweenka qaba lafo-beelka. Laakiin uma shaqeyso si ka wanaagsan ilaha kale ee kaalshiyamka, sida kaalshiyamka kaarboonayt.
• Dhibaatooyinka ka dhasha cunista dadka horey macluul u qabay (reursing syndrome). Daraasad hore waxay muujineysaa in sodium iyo potassium fosfateerka la siiya xididada (IV) in ka badan 24 saacadood waxay ka hortageysaa in cudurka dib loo cuno marka dib loo bilaabayo nafaqada dadka ay hayso nafaqada daran ama gaajaysan.
• Ilkaha xasaasiga ah.
• Xaaladaha kale.

Cadeymo dheeri ah ayaa loobaahanyahay si loogu qiimeeyo cusbada fosfateerka adeegyadan.

Phosphates caadi ahaan waxaa laga helaa cuntada waana kiimikooyin muhiim u ah jirka. Waxay ku lug leeyihiin qaab dhismeedka unugga, gaadiidka tamarta iyo keydinta, shaqada fiitamiinka, iyo habab kale oo badan oo muhiim u ah caafimaadka. Cusbadaha fosfaatku waxay u dhaqmi karaan sidii dawada caloosha jilcisa iyagoo keenaya dheecaan badan oo lagu soo jiito xiidmaha iyo kicinta xiidmaha si ay dhaqso ugu soo saaraan waxyaabaha ku jira.

Cusbada fosfateedka ay ku jiraan sodium, potassium, aluminium, ama kaalshiyamka waa KU SOO DHAWEYN SAFE dadka badankood marka afka la galiyo, malawadka la galiyo, ama la siiya xididka (IV) si ku habboon iyo muddo gaaban. Cusbada fosfate ga ah waa in kaliya loo isticmaalaa xididka (IV) iyadoo la kormeerayo dhaqtarka.

Cusbada fosfateedka (oo loo muujiyo inay tahay fosfoor) waa Suuragal AAN LAHAYN markii lagu qaato qadar ka sarreeya 4 garaam maalintii dadka waaweyn ee ka yar da'da 70 sano iyo 3 garaam maalintii dadka waaweyn.

Isticmaalka muddada-dheer ee joogtada ahi wuxuu kicin karaa dheelitirka fosfoorasyada iyo kiimikooyinka kale ee jidhka ku jira waana in lala socdo xirfad-yaqaan daryeel caafimaad si looga fogaado waxyeelo daran. Cusbada fosfate waxay xanuujin kartaa habka dheef-shiidka waxayna sababi kartaa calool xanuun, shuban, calool fadhi, madax xanuun, daal, iyo dhibaatooyin kale.

Ha ku khaldin cusbada fosfateerka walxaha sida organophosphates, ama Tribasic sodium phosphates iyo tribasic potassium phosphates, oo aad sun u ah.

Taxaddarrada gaarka ah & digniinta:

Uurka iyo nuujinta: Cusbada fosfateedka laga helo ilaha cuntada waa KU SOO DHAWEYN SAFE loogu talagalay haweenka uurka leh ama naas nuujinaya marka loo isticmaalo gunnooyinka lagu taliyay ee ah 1250 mg maalin kasta hooyooyinka u dhexeeya 14-18 sano jir iyo 700 mg maalin kasta kuwa ka weyn 18 sano. Qadarka kale waa Suuragal AAN LAHAYN waana in loo adeegsadaa oo kaliya la talinta iyo daryeelka joogtada ah ee xirfadlaha daryeelka caafimaadka.

Caruurta: Cusbada fosfateedka waa KU SOO DHAWEYN SAFE loogu talagalay carruurta markii loo isticmaalo gunnooyinka maalinlaha ah ee lagula taliyay ee ah 460 mg carruurta da'doodu tahay 1-3 sano; 500 mg carruurta 4-8 sano jir ah; iyo 1250 mg carruurta da'doodu tahay 9-18 sano. Cusbada fosfateedka ayaa ah Suuragal AAN LAHAYN haddii xaddiga fosfateedka la cuno (oo loo muujiyo fosfoor ahaan) uu ka bato heerka qaadashada sare ee loo dulqaadan karo (UL). ULs waa 3 garaam maalintii carruurta jirta 1-8 sano; iyo 4 garaam maalintii oo loogu talagalay carruurta 9 sano iyo wixii ka weyn.

Wadne xanuun: Iska ilaali inaad isticmaasho cusbada fosfateerka ay ku jiraan soodhiyamku haddii aad wadne xanuun qabto.

Haynta dareeraha (barar): Iska ilaali inaad isticmaasho cusbada fosfateerka ay ku jirto soodhiyamku haddii aad qabtid cirrhosis, wadne xanuun, ama xaalado kale oo sababi kara barar.

Heerarka sare ee kaalshiyamka dhiigga (hypercalcemia): Si taxaddar leh u isticmaal cusbada fosfateerka haddii aad qabtid hypercalcemia. Fosfooraska badan wuxuu sababi karaa kaalshiyam in lagu keydiyo meesha aysan kujirin jirkaaga.

Heerarka sare ee fosfateedka dhiiga: Dadka qaba cudurka Addison, wadnaha iyo sambabaha oo aad u xanuunsada, cudurada kalyaha, dhibaatooyinka tayroodh, ama beer xanuunku waxay u badan yihiin dadka kale inay ku dhacaan fosfooras aad u badan oo ku dhaca dhiigooda markay qaataan cusbada fosfateerka. U isticmaal cusbada fosfateerka kaliya talada iyo daryeelka socda ee xirfadlaha daryeelka caafimaadka haddii aad leedahay mid ka mid ah xaaladahaas.

Cudurka kilyaha: U isticmaal cusbada fosfateerka oo keliya talooyinka iyo daryeelka joogtada ah ee xirfadlaha daryeelka caafimaadka haddii aad dhibaato ka haysato kilyaha.

Dhexdhexaad

Ka taxaddar isku-dhafkan.

Bisphosphonates

Daawooyinka Bisphosphonate iyo cusbada fosfateerka labaduba waxay hoos u dhigi karaan heerarka kaalshiyamka ee jirka ku jira. Qaadashada xaddi badan oo cusbada fosfateerka ah oo ay weheliso daawooyinka loo yaqaan 'bifsphonate' waxay sababi karaan heerarka kaalshiyamku inay aad u hooseeyaan.

Qaar ka mid ah bisphosphonates waxaa ka mid ah alendronate (Fosamax), etidronate (Didronel), risedronate (Actonel), tiludronate (Skelid), iyo kuwa kale.

Kaalshiyamka

Fosfaatku wuxuu isku dari karaa kaalshiyamka. Tani waxay yareynaysaa awoodda jirku u leeyahay inuu soo nuugo fosfateerka iyo kaalshiyamka. Si looga fogaado isdhexgalkaan, fosfateerka waa in laqaataa ugu yaraan 2 saac kahor ama kadib qaadashada kaalshiyamka.

Birta

Fosfaatku wuxuu isku dari karaa birta. Tani waxay yareynaysaa awoodda jirku u leeyahay inuu soo nuugo fosfateerka iyo birta. Si looga fogaado isdhexgalkaan, fosfateerka waa in la qaataa ugu yaraan 2 saacadood kahor ama kadib qaadashada birta.

Magnesium

Fosfate ayaa isku dari kara magnesium. Tani waxay yareynaysaa awoodda jirku u leeyahay inuu soo nuugo fosfateerka iyo magnesium. Si looga fogaado isdhexgalkaan, fosfateerka waa in la qaataa ugu yaraan 2 saacadood kahor ama kadib qaadashada magnesium.

Cunnooyinka iyo cabbitaanka ay ku jirto fosfateetka

Aragti ahaan, qaadashada fosfateerka oo leh cunnooyinka ay ku jiraan fosfateerka iyo cabitaannada ayaa kordhin kara heerarka fosfateerka waxayna kordhin kartaa halista waxyeellooyinka, gaar ahaan dadka qaba dhibaatooyinka kelyaha. Cunnooyinka ay ku jirto fosfateetka iyo cabitaannada waxaa ka mid ah koola, khamri, biir, badarka miraha laga sameeyo, lowska, waxyaabaha caanaha laga sameeyo iyo hilibka qaarkood.

Qiyaasaha soo socda ayaa lagu bartay cilmi baarista sayniska:

AFKA:

• Kordhinta heerarka fosfateerka ee aad u hooseeya: Bixiyeyaasha daryeelka caafimaadku waxay cabbiraan heerarka fosfateerka iyo kaalshiyamka ku jira dhiigga waxayna siiyaan kaliya fosfateer ku filan oo lagu saxo dhibaatada.
• Hoos u dhigida heerarka kaalshiyamka oo aad u sareeya: Bixiyeyaasha daryeelka caafimaadku waxay cabbiraan heerarka fosfateerka iyo kaalshiyamka ku jira dhiigga waxayna siiyaan kaliya fosfateer ku filan oo lagu saxo dhibaatada.
• Diyaarinta mindhicirka hawl caafimaad: Saddex illaa afar kiniin oo laguu qoro (OsmoPrep, Salix Pharmaceuticals; Visicol, Salix Pharmaceuticals) mid kasta oo ka kooban 1.5 garaam oo sodium fosfate ah ayaa lagu qaataa 8 wiqiyadood oo biyo ah 15kii daqiiqaba wadar ahaan 20 kiniin ah fiidka ka hor baarista walamadka. Subaxda xigta, 3-4 kiniin ah ayaa laqaadayaa 8 wiqiyadood oo biyo ah 15kii daqiiqoba mar ilaa inta laga qaadayo 12-20 kiniin.
• Dhagaxyada kilyaha (nephrolithiasis): Cusbada iyo sodium phosphate cusbada oo bixisa 1200-1500 mg oo walxaha aasaasiga ah ee phosphate maalin kasta ayaa la isticmaalay.

BY IV:

• Kordhinta heerarka fosfateerka oo aad u hooseeya: Waxsoosaarka xididka (IV) oo ay ku jiraan sodium phosphate ama potassium phosphate ayaa la isticmaalay. Qiyaasaha 15-30 mmol waxaa la siiyay in ka badan 2-12 saacadood. Qiyaaso sare ayaa la isticmaalay haddii loo baahdo.

Gunooyinka maalinlaha ah ee lagu taliyay (RDAs) ee fosfateerka (oo loo muujiyo fosfooraska) waa: Carruurta 1-3 sano, 460 mg; carruurta 4-8 sano, 500 mg; ragga iyo dumarka 9-18 sano, 1250 mg; ragga iyo dumarka ka weyn 18 sano, 700 mg.
Qaadashada ku filan (AI) ee dhallaanka waa: 100 mg loogu talagalay dhallaanka 0-6 bilood jira iyo 275 mg loogu talagalay dhallaanka 7-12 bilood jira.
Heerarka Qaadashada Sare ee Loo Dulqaadan Karo (UL), heerka qaadashada ugu sarreysa ee aan laga fileynin waxyeellooyin aan loo baahnayn, fosfateerka (oo loo muujiyo fosfooraska) maalintii waa: carruurta 1-8 sano, 3 garaam maalintii; carruurta iyo dadka waaweyn 9-70 sano, 4 garaam; dadka waaweyn ee ka weyn 70 sano, 3 garaam; haweenka uurka leh 14-50 sano, 3.5 garaam; iyo naasnuujinta haweenka 14-50 sano, 4 garaam. Aluminium fosfateet, fone fosfate, kalsiyam fosfat, kaalshiyam orhophosphate, kaalshiyam fosfate dibhisic anhydrous, kaalshiyam fosfate-lafo ash, kalsiyam fosfate fadeexad diasid, kalsiyam fosfate , Fosfat-Di-Kaalshiyam, Fistiifiyada Dicalcium, Fishatooyinka Dical calcium, Feefooyinka kalsiyum ee faafan, Orthophosphate de Calcium, Fosfate d'Aluminium, Fosfate de kaalshiyo, Fosfate de Magnésium, Fosfate Neutre de Kaalshiyam, Fosfate d 'Os, Fosfateellada Tricalcium, Digniin, Précipitation du Phosphate de Calcium, Précipité de Phosphate de Calcium, Tertiary Calcium Phosphate, Tricalcium Phosphate, Whitlockite, Magnesium Phosphate, Merisier, Potassium fosfate, Dibasic Potassium Fosfate, Dibloomaasiyamka Hydrogen Orthophosphate, Diblossasium Fosfate fosfate, , Potassium Biphosphate, Potassium Dihydrogen Orthophosphate, Potassium Hydrogen Phosphate, Phosphate de Dipotassium, Fosfat d’Hydrogène de Potassium, Fosfate de Potassium, Fosfate de Potasima Dibasique, Fosfate de Potassium Monobasique, Sodium phosphate, Anhydrous Sodium Phosphate, Dibasic Sodium Phosphate, , Disodium Hydrogen Orthophosphate Dodecahydrate, Disodium Hydrogen Phosphate, Disodium Phosphate, Fosfate of Soda, Sales de Fosfato, Sels de Phosphate, Sodium Orthophosphate, Orthophosphate Disodique d'Hydrogène, Phosphate Disodique d'Hydrogène, Orthophotes, de Sodium Dibasique, Fosfooraska.

Si aad wax badan uga ogaato sida maqaalkan loo qoray, fadlan eeg Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran habka.

1. Kiniiniyada Visicol Qorista macluumaadka. Daawooyinka Salix, Raleigh, NC. Maarso 2013. (https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf). La helay 09/28/17.
2. Delegge M, Kaplan R. Waxtarka u diyaargarowga mindhicirka iyadoo la adeegsanayo horay loo soo baakadeeyay, cunno yar oo fiber leh soodhiyam hooseeya, magnesium citrate cathartic iyo dheecaan cad oo leh sodium phosphate cathartic caadi ah. Aliment Pharmacol Ther. 2005 Jun 15; 21: 1491-5. Eeg aragti
3. Johnson DA, Barkun AN, Cohen LB, iyo al.; US Task Force-Task Force on Multirect Cancer. Ku-hagaajinta Ku-filnaanshaha Nadiifinta Mindhicirka 'Colonoscopy': Talooyin ay soo jeediyeen Kooxda Task-Bulsho-wada-jirka ah ee Mareykanka ee Kansarka Mindhicirka Am J Gastroenterol 2014; 109: 1528-45. Eeg aragti
4. Nam SY, Choi IJ, Park KW, Ryu KH, Kim BC, Sohn DK, Nam BH, Kim CG.Khatarta gastropathy-ka dhiigbaxa leh ee la xiriirta diyaarinta mindhicirka walamadka iyadoo la adeegsanayo xalka sodium phosphate xalka. Endoskobi. 2010 Febraayo; 42: 109-13. Eeg aragti
5. Ori Y, Rozen-Zvi B, Chagnac A, Herman M, Zingerman B, Atar E, Gafter U, Korzets A. Dhimasho iyo cilad-darrooyinka dheef-shiid kiimikaadka daran ee la xiriira adeegsiga sodium fosfate enemas: khibrad hal xarun ah. Arch Intern Med. 2012 Febraayo 13; 172: 263-5. Eeg aragti
6. Ladenhauf HN, Stundner O, Spreitzhofer F, Deluggi S. hyperphosphatemia daran kadib maamulida sodium-fosfate oo ay kujiraan calool jilciyeyaasha carruurta: taxanaha kiisaska iyo dib u eegista nidaamsan ee suugaanta. Pediatr Surg Int. 2012 Agoosto; 28: 805-14. Eeg aragti
7. Schaefer M, Littrell E, Khan A, Patterson ME. Qiyaasta GFR Hoos udhaca Kadib Sodium Phosphate Enemas iyo Polyethylene Glycol oo loogu talagalay baaritaanka baaritaanka baarista baaritaanka: Daraasad Wadahadal Dib-u-eegis ah. Am J Kilyaha Dis. 2016 Apr; 67: 609-16. Eeg aragti
8. Brunelli SM. Xiriirka ka dhexeeya u diyaar garowga mindhicirka sodium fosfateerka iyo dhaawaca kelyaha: dib u eegis nidaamsan iyo falanqayn meta ah. Am J Kilyaha Dis. Maryan 2009; 53: 448-56. Eeg aragti
9. Choi NK, Lee J, Chang Y, Kim YJ, Kim JY, Heesta HJ, Shin JY, Jung SY, Choi Y, Lee JH, Park BJ. Hoos udhaca kelyaha oo ba'an kadib soodiyamka sodium fosfateerka caloosha: daraasad kiis-iskudhaf ah oo dalka oo dhan ah. Endoskobi. 2014 Juun; 46: 465-70. Eeg aragti
10. Belsey J, Crosta C, Epstein O, Fischbach W, Lakabka P, Parente F, Halphen M. Meta-falanqaynta: waxtarka qaraabada ee u diyaargarowga mindhicirka afka ee baarista walamadka 1985-2010. Aliment Pharmacol Ther. 2012 Jan; 35: 222-37. Eeg aragti
11. Belsey J, Crosta C, Epstein O, Fischbach W, Lakabka P, Parente F, Halphen M. Meta-falanqaynta: waxtarka diyaarinta mindhicirka yar ee endoscopy capsule video caloosha yar. Aragtida 'Curr Med Res Opin'. 2012 Dec; 28: 1883-90. Eeg aragti
12. Czuba M, Zajac A, Poprzecki S, Cholewa J, Woska S. Saamaynta Sodium Phosphate Loading ee Aerobic Power iyo Capacity ee Wadooyinka Baaskiiladaha Wadooyinka. J Sports Sci Med. 2009 Dec 1; 8: 591-9. Eeg aragti
13. Brewer CP, Dawson B, Wallman KE, Guelfi KJ. Saameynta soo-celinta soodhiyamka soodhiyamka ah ee soo noqnoqda ee waxqabadka baaskiil-tijaabada waqtiga iyo VO2peak. Int J Sport Nutr Jimicsiga Metab. 2013 Abriil; 23: 187-94. Eeg aragti
14. Buck CL, Wallman KE, Dawson B, Guelfi KJ. Sodium fosfate ahaan caawimaad ergogenic. Isboortiga Med. 2013 Juun; 43: 425-35. Eeg aragti
15. Buck CL, Dawson B, Guelfi KJ, McNaughton L, Wallman KE. Kordhinta sodium fosfateerka iyo waxqabadka tijaabada waqtiga ee baaskiiladaha dumarka. J Sports Sci Med. 2014 Sep 1; 13: 469-75. Eeg aragti
16. Brewer CP, Dawson B, Wallman KE, Guelfi KJ. Saameynta Kordhinta Sodium Phosphate ee Waxqabadka Tijaabada Waqtiga Baaskiilka iyo VO2 1 iyo 8 Maalmaha Boostada Kadib. J Sports Sci Med. 2014 Sep 1; 13: 529-34. Eeg aragti
17. West JS, Ayton T, Wallman KE, Guelfi KJ. Saamaynta 6 maalmood ee kaabis sodium fosfateed leh oo ku saabsan rabitaanka cuntada, qaadashada tamarta, iyo awoodda aerobic ee ragga iyo haweenka tababaran. Int J Sport Nutr Jimicsiga Metab. 2012 Diis; 22: 422-9. Eeg aragti
18. van Vugt van Pinxteren MW, van Kouwen MC, van Oijen MG, van Achterberg T, Nagengast FM. Daraasad mustaqbalka ah ee u diyaargarowga mindhicirka ee colonoscopy oo leh xalka polyetylen glycol-electrolyte iyo sodium phosphate ee Lynch syndrome: tijaabo la kala soocay. Kansarka Fam. 2012 Sep; 11: 337-41. Eeg aragti
19. Lee SH, Lee DJ, Kim KM, Seo SW, Kang JK, Lee EH, Lee DR. Isbarbardhiga waxtarka iyo badbaadada kiniiniyada sodium fosfateerka iyo xalka polyetylen glycol ee nadiifinta mindhicirka ee dadka waaweyn ee reer Kuuriya. Yonsei Med J. 2014 Nov; 55: 1542-55. Eeg aragti
20. Kopec BJ, Dawson BT, Buck C, Wallman KE. Saamaynta sodium fosfateerka iyo kafeyn-qaadashada ku-celinta awoodda soo-noqnoqodka ee ciyaartoyda labka ah. J Sci Med Sport. 2016 Mar; 19: 272-6. Eeg aragti
21. Jung YS, Lee CK, Kim HJ, Eun CS, Han DS, Park DI. Tijaabinta la kantaroolay ee tijaabada ah ee kiniiniyada sodium fosfate ee loo yaqaan 'polyethylene glycol solution' ee loogu talagalay nadiifinta mindhicirka mindhicirka. World J Gastroenterol. 2014 Nofeembar 14; 20: 15845-51. Eeg aragti
22. Heaney RP, Recker RR, Watson P, Lappe JM. Fosfateetka iyo kaarboonate-ka cusbada kalsiyumku waxay taageertaa dhismaha lafaha adag ee lafo-beelka. Am J Clin Nutr. 2010 Jul; 92: 101-5. Eeg aragti
23. Ell C, Fischbach W, Layer P, Halphen M. Randomized, tijaabin kontorool ah 2 L polyetylen glycol oo lagu daray qaybaha ascorbate iyo sodium fosfate ee nadiifinta mindhicirka kahor baarista walamadka ee kansarka. Aragtida 'Curr Med Res Opin'. 2014 Dec; 30: 2493-503. Eeg aragti
24. Buck CL, Henry T, Guelfi K, Dawson B, McNaughton LR, Wallman K. Saamaynta sodium fosfate iyo kaabista beetroot ee ku-celcelinta awoodda dheddigga. Eur J Appl Physiol. 2015 Oktoobar; 115: 2205-13. Eeg aragti
25. Buck C, Guelfi K, Dawson B, McNaughton L, Wallman K. Saamaynta sodium fosfate iyo kafeyn ku shubista awoodda soo noqnoqoshada. J Ciyaaraha Sci. 2015; 33: 1971-9. Eeg aragti
26. Brewer CP, Dawson B, Wallman KE, Guelfi KJ. Saameynta kaabista sodium fosfateetka ee dadaalka baaskiil wadidda ee soo noqnoqda. J Ciyaaraha Sci. 2015; 33: 1109-16. Eeg aragti
27. Folland, JP, Stern, R, iyo Brickley, G. Sodium fosfateerka culeyska ayaa hagaajinaya waxqabadka shaybaarka baaskiil wadida waqtiga tijaabada ee baaskiillayaal tababaran. J Sci Med Sport 2008; 11: 464-8. Eeg aragti
28. Fisher, JN iyo Kitabchi, AE. Daraasad aan kala sooc lahayn oo ku saabsan daaweynta fosfateerka daaweynta ketoacidosis ee sonkorowga. J Clin Endocrinol Metab 1983; 57: 177-80. Eeg aragti
29. Terlevich A, Maqalka SD, Woltersdorf WW, iyo al. Reaction syndrome: daaweyn wax ku ool ah oo ammaan ah oo leh Phosphates Polyfusor. Aliment Pharmacol Ther 2003; 17: 1325-9. Eeg aragti
30. Savica, V, Calo, LA, Monardo, P, iyo al. Fosfooraska candhuufta iyo fosfateerka cabitaannada: saamaynta daaweynta uremic hyperphosphatemia. J Ren Nutr 2009; 19: 69-72. Eeg aragti
31. Hu, S, Shearer, GC, Steffes, MW, Harris, WS, iyo Bostom, AG. Niacin-maalin-kordhin-sii-deyn ah ayaa hoos u dhigta isku-uruurinta serum fosfooraska ee bukaannada qaba cilladda dheef-shiid kiimikaadka 'dyslipidemia'. Am J Kilyaha Dis 2011; 57: 181-2. Eeg aragti
32. Schaiff, RA, Hall, TG, iyo Baarka, RS. Daaweynta caafimaadka ee 'hypercalcemia'. Clin Pharm 1989; 8: 108-21. Eeg aragti
33. Elliott, GT iyo McKenzie, MW. Daaweynta hypercalcemia. Dawada Intell Clin Pharm 1983; 17: 12-22. Eeg aragti
34. Bugg, NC iyo Jones, JA. Hypophosphataemia. Pathophysiology, saamaynta iyo maaraynta qaybta daryeelka degdegga ah. Suuxdinta 1998; 53: 895-902. Eeg aragti
35. OsmoPrep Qoritaanka macluumaadka. Daawooyinka Salix, Raleigh, NC. Oktoobar 2012. (http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021892s006lbl.pdf, la helay 02/24/15).
36. Liiska maaddooyinka FDA OTC, Abriil 2010. Waxaa laga heli karaa: www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM135691.pdf (waxaa laga helay 2/7/15).
37. Finkelstein JS, Klibanski A, Arnold AL, iyo al. Kahortaga luminta lafa-beelka laxiriira estrogen ee hormoonka bini'aadamka parathyroid- (1-34): tijaabin kontoroollaysan oo laxakumay. JAMA 1998; 280: 1067-73. Eeg aragti
38. Guuleyste KK, Ko CW, Reynolds JC, et al. Daaweynta muddada-dheer ee hypoparathyroidism: Daraasad la xakameynayo oo la xakameynayo oo la barbardhigayo hormoonka parathyroid (1-34) oo ka soo horjeeda calcitriol iyo kalsiyum. J Clin Endocrinol Metab 2003; 88: 4214-20. Eeg aragti
39. Lindsay R, Nieves J, Formica C, iyo al. Daraasad la kantaroolay oo aan kala sooc lahayn oo ku saabsan saameynta hormoonka parathyroid ee laf-dhabarka laf-dhabarka iyo jabka ku dhaca haweenka postmenopausal on estrogen oo leh osteoporosis. Lancet 1997; 350: 550-5. Eeg aragti
40. Winer KK, Yanovski JA, Cutler GB Jr. Synthetic human parathyroid hormone 1-34 vs calcitriol iyo kalsiyum ee daaweynta hypoparathyroidism. JAMA 1996; 276: 631-6. Eeg aragti
41. Leung AC, Henderson IS, Halls DJ, Dobbie JW. Aluminium hydroxide ka soo horjeedda sucralfate oo ah fosfateerka isku xidha uraemia. Br Med J (Clin Res Ed) 1983; 286: 1379-81. Eeg aragti
42. Roxe DM, Mistovich M, Barch DH. Saameynaha fosfate-ku-xirnaanta ee ku-meel-gaadhka ah ee bukaanka qaba kelyaha ee joogtada ah. Am J Kilyaha Dis 1989; 13: 194-9. Eeg aragti
43. Hergesell O, Ritz E. Phosphate waxay ku xiran tahay birta: aragti cusub? Kelyaha Intl Suppl 1999; 73: S42-5. Eeg aragti
44. Peters T, Apt L, Ross JF. Saamaynta fosfooraska marka la nuugo birta oo lagu barto maadooyinka caadiga ah ee aadanaha iyo qaabka tijaabada iyadoo la adeegsanayo sifaynta kalyaha. Gastroenterology 1971; 61: 315-22. Eeg aragti
45. Monsen ER, Cook JD. Nuugista birta cuntada maadooyinka aadanaha IV. Saamaynta kalsiyum iyo cusbada fosfateerka ku saabsan nuugista birta aan kulaylka lahayn. Am J Clin Nutr 1976; 29: 1142-8. Eeg aragti
46. Lindsay R, Nieves J, Henneman E, iyo al. Maamulka hoose ee qaybta amino-terminal ee bini-aadamka hormoonka parathyroid- (1-34): kinetics iyo jawaabta biochemical ee bukaanjiifka osteoporotic estrogenized. J Clin Endocrinol Metab 1993; 77: 1535-9. Eeg aragti
47. Campisi P, Badhwar V, Morin S, Trudel JL. Teetanada ka dib 'hypocalcemic tetany' oo ay sababto diyaarinta 'Fleet Phospho-Soda' ee bukaan qaadashada sodium alendronate. Rugta Qalitaanka 'Colon Rectum' 1999; 42: 1499-501. Eeg aragti
48. Loghman-Adham M. Badbaadada fureyfateerka cusub ee loogu talagalay cilladda kelyaha ee joogtada ah. Dawada Saf 2003; 26: 1093-115. Eeg aragti
49. Schiller LR, Santa Ana CA, Sheikh MS, iyo al. Saameynta waqtiga maamulka kalsiyum acetate ee ku xirnaanta fosfooraska. New Engl J Med 1989; 320: 1110-3. Eeg aragti
50. Saadeh G, Bauer T, Licata A, Sheeler L. Antacid-sababtay osteomalacia. Cleve Clin J Med 1987; 54: 214-6. Eeg aragti
51. Gregory JF. Daraasad kiis: bioavailability folate J Nutr 2001; 131: 1376S-1382S. Eeg aragti
52. Insogna KL, Bordley DR, Caro JF, Lockwood DH. Osteomalacia iyo daciifnimo ka timaadda quudinta antacid xad-dhaaf ah. JAMA 1980; 244: 2544-6. Eeg aragti
53. Heaney RP, Nordin BE. Saamaynta kaalshiyamka ee ku saabsan nuugista fosfooraska: saamaynta ka hortagga iyo wada-daaweynta ee lafo-beelka. J Am Coll Nutr 2002; 21: 239-44 .. Eeg aragti aan la taaban karin.
54. Rosen GH, Boullata JI, O'Rangers EA, iyo al. Nidaamka buuxinta fosfat-ka xididka ee bukaanka aadka u xanuunsan ee qaba hypophosphatemia dhexdhexaad ah. Daryeelka Crit Med Med 1995; 23: 1204-10. Eeg aragti
55. Perreault MM, Ostrop NJ, Tierney MG. Wax ku oolnimada iyo amniga beddelidda fosfateerka xididdada bukaannada halista ah. Ann Farmashiye 1997; 31: 683-8. Eeg aragti
56. Duffy DJ, Conlee RK. Saamaynta fosfateerka ku xirnaanta awoodda lugta iyo jimicsiga treadmill-ka ee xoogga weyn. Jimicsiga Isboortiga Med Sci 1986; 18: 674-7. Eeg aragti
57. Guddiga Cuntada iyo Nafaqada, Machadka Daawada. Tixraacyada Cunnooyinka ee loo Qaado Kaalshiyamka, Fosfooraska, Magnesium, Faytamiin D, iyo Fluoride. Washington, DC: National Academy Press, 1999. Waxaa laga heli karaa: http://books.nap.edu/books/0309063507/html/index.html.
58. Carey CF, Lee HH, Woeltje KF (eds). Buugga Washington ee Daaweynta Caafimaadka. 29aad. New York, NY: Lippincott-Raven, 1998.
59. Alvarez-Arroyo MV, Traba ML, Rapado TA, iyo al. Xiriirinta udhaxeysa 1.25 dihydroxyvitamin D heerarka serum iyo heerka jajabka ee nuugista kalsiyum ee mindhicirka ee hypercalciuric nephrolithiasis. Doorka fosfateerka. Urol Res 1992; 20: 96-7. Eeg aragti
60. Heaton KW, Lever JV, Barnard RE. Osteomalacia oo la xidhiidha daaweynta cholestyramine ee loogu talagalay shubanka post-ileectomy. Gastroenterology 1972; 62: 642-6. Eeg aragti
61. Becker GL. Kiiska ka dhanka ah saliidda macdanta. Am J Dheef-shiidka Dis 1952; 19: 344-8. Eeg aragti
62. Schwarz KB, Goldstein PD, Witztum JL, iyo al. Isku-uruurinta fiitamiin-isku-dhafan ee carruurta 'hypercholestrolemic' ee lagu daaweeyo colestipol. Dhakhaatiirta carruurta 1980; 65: 243-50. Eeg aragti
63. West RJ, Lloyd JK. Saameynta cholestyramine ee nuugista xiidmaha. Guut 1975; 16: 93-8. Eeg aragti
64. Spencer H, Menaham L. Dhibaatooyinka xun ee aluminium-ku jira antacids ee ku saabsan dheef-shiid kiimikaadka. Gastroenterology 1979; 76: 603-6. Eeg aragti
65. Roberts DH, Knox FG. Qabashada fosfateerka kiliyaha iyo kalsiyum nephrolithiasis: doorka fosfateerka cuntada iyo daadashada fosfateerka. Semin Nephrol 1990; 10: 24-30. Eeg aragti
66. Harmelin DL, Martin FR, Wark JD. Cudurka yaraanta fosfateerka ee 'antacid-induced' oo soo bandhigta nephrolithiasis. Aust NZ J Med 1990; 20: 803-5. Eeg aragti
67. Yates AA, Schlicker SA, Suitor CW. Tixraacyada tixraaca cuntada: Saldhigga cusub ee talooyinka loogu talagalay kaalshiyamka iyo nafaqooyinka la xiriira, fiitamiinnada B, iyo choline. J Am Cuntada Assoc 1998; 98: 699-706. Eeg aragti
68. Fauci AS, Braunwald E, Isselbacher KJ, iyo al. Mabaadi'da Harrison ee Daawada Gudaha, tirsiga 14aad. New York, NY: McGraw-Hill, 1998.
69. Shils ME, Olson JA, Shike M, Ross AC, eds. Nafaqada casriga ah ee caafimaadka iyo cudurada. 9aad. Baltimore, MD: Williams & Wilkins, 1999.
70. Galloway SD, Tremblay MS, Sexsmith JR, Roberts CJ. Saameynta kaabis fosfateedka daran ee maadooyinka heerarka jimicsiga aerobic kala duwan. Eur J Appl Physiol Shaqada Physiol 1996; 72: 224-30. Eeg aragti
71. Helikson MA, Parham WA, Tobias JD. Hypocalcemia iyo hyperphosphatemia ka dib isticmaalka fosfate enema ee cunugga. J Pediatr Surg 1997; 32: 1244-6. Eeg aragti
72. Diunesma JA, Buckley SE, Warner BA, iyo al. Waxyeelada kiimikada ee sodium fosfooraska afka. Dig Dis Sci 1996; 41: 749-53. Eeg aragti
73. Fine A, Patterson J. Cadaadiska daran ee hyperphosphatemia ka dib maamulka fosfate ee diyaarinta mindhicirka bukaanka qaba kelyaha: laba xaaladood iyo dib u eegista suugaanta. Am J Kilyaha Dis 1997; 29: 103-5. Eeg aragti
74. Clarkston WK, Tsen TN, Dies DF, iyo al. Afka sodium fosfateerka ka soo horjeedka sulfate-free polyetylen glycol electrolyte lavage xal u diyaarinta bukaan socodka ee colonoscopy: isbarbardhiga mustaqbalka. Gastrointest Endosc 1996; 43: 42-8. Eeg aragti
75. Hill AG, Teo W, Weli A, iyo al. Hoos u dhaca kuleylka jirka wuxuu saadaal u yahay hypokalaemia ka dib afka sodium fosfooraska afka. Aust N Z J Surg 1998; 68: 856-8. Eeg aragti
76. Heller HJ, Reza-Albarran AA, Breslau NA, Pak CY. Yaraynta joogtada ah ee kalsiyumka kaadi-mareenka inta lagu jiro daaweynta muddada-dheer iyadoo si tartiib tartiib ah loo sii daayo fosfaatka fosfat-ka ah ee dhexdhexaadka ah ee ku jira 'hypercalciuria'. J Urol 1998; 159: 1451-5; dood 1455-6. Eeg aragti
77. Hardman JG, Limbird LL, Molinoff PB, eds. Goodman iyo Gillman's Aasaaska Farmasiga ee Daaweynta, 9aad ed. New York, NY: McGraw-Hill, 1996.
78. Dhalinyarada DS. Saamaynta Daroogadu ku leedahay Tijaabooyinka Sheybaarka Caafimaadka 4aad. Washington: AACC Press, 1995.
79. McEvoy GK, ed. Macluumaadka Dawooyinka AHFS. Bethesda, MD: Bulshada Mareykanka ee Farmashiistayaasha Nidaamka Caafimaadka, 1998.
80. Monographs ku saabsan isticmaalka daawooyinka ee daawooyinka dhirta. Exeter, UK: Iskaashatada Sayniska Yurub ee Phytother, 1997.

Markii ugu dambeysay ee dib loo eegay - 01/29/2019